Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2006; 12(31): 5060-5063
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.5060
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.5060
Table 1 Clinical data of 1126 patients
Group | Cases(n) | Size of tumor (cm) | Clinical staging | Liver function level | ||||||
< 5 | 5-10 | > 10 | I | II | III | A | B | C | ||
Preop. TACE | 258 | 20 | 145 | 93 | 104 | 154 | 0 | 155 | 103 | 0 |
Postop.TACE | 154 | 9 | 76 | 69 | 16 | 138 | 0 | 83 | 71 | 0 |
TACE + RFA | 126 | 3 | 57 | 66 | 48 | 57 | 21 | 92 | 34 | 0 |
TACE | 469 | 31 | 239 | 199 | 156 | 251 | 62 | 252 | 197 | 20 |
TAI | 119 | 11 | 47 | 61 | 28 | 47 | 44 | 14 | 73 | 32 |
Total | 1126 | 74 | 564 | 488 | 352 | 647 | 127 | 596 | 478 | 52 |
- Citation: Liu YM, Qin H, Wang CB, Fang XH, Ma QY. Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World J Gastroenterol 2006; 12(31): 5060-5063
- URL: https://www.wjgnet.com/1007-9327/full/v12/i31/5060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i31.5060